Drugs firm 'abused position to boost profits'
HOUSEHOLD goods company Reckitt Benckiser has been accused of abusing its dominant position in the supply of heartburn medicines to the NHS.
The Office of Fair Trading alleges that Reckitt sought to manipulate a system used by GPs so they would prescribe a more expensive version of the product rather than a considerably cheaper generic equivalent.
The OFT said it would wait for a response from Reckitt before giving a final verdict on whether it believes competition law has been broken.
But Reckitt, which employ about 1,300 people in Hull, claimed it "competes fairly and within the letter and spirit of the law in all of our operations".